VANCOUVER, BC, June 3, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to vaccine rules. Continue Reading View Comments "Kalkine Media dolor sit amet, ...

The cuts will shutter two major HIV vaccine research efforts, and a National Institutes of Health senior official said the ...

Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...

Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

U.S. equities were mixed at midday after China accused the U.S. of violating a trade deal the two countries reached last ...

A man with a makeshift flamethrower attacked a group of people in Boulder, Colorado, calling for the release of Israeli ...

In a recent social media post, Marjorie Taylor Greene criticized the Food and Drug Administration after the agency approved a ...